These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

498 related items for PubMed ID: 2603146

  • 1. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors.
    Jeziorski M, White FJ.
    Synapse; 1989; 4(4):267-80. PubMed ID: 2603146
    [Abstract] [Full Text] [Related]

  • 2. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR, Hu XT, Galloway MP, White FJ.
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [Abstract] [Full Text] [Related]

  • 3. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: repeated administration.
    Henry DJ, Greene MA, White FJ.
    J Pharmacol Exp Ther; 1989 Dec; 251(3):833-9. PubMed ID: 2557418
    [Abstract] [Full Text] [Related]

  • 4. Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens.
    Henry DJ, White FJ.
    J Pharmacol Exp Ther; 1991 Sep; 258(3):882-90. PubMed ID: 1890623
    [Abstract] [Full Text] [Related]

  • 5. Ontogeny of nigrostriatal dopamine neuron autoreceptors: iontophoretic studies.
    Wang L, Pitts DK.
    J Pharmacol Exp Ther; 1995 Jan; 272(1):164-76. PubMed ID: 7815330
    [Abstract] [Full Text] [Related]

  • 6. Electrophysiological effects of putative autoreceptor-selective dopamine agonists on A10 dopamine neurons.
    Ackerman JM, Johansen PA, Clark D, White FJ.
    J Pharmacol Exp Ther; 1993 May; 265(2):963-70. PubMed ID: 8098768
    [Abstract] [Full Text] [Related]

  • 7. Apparent mediation of the stimulus properties of a low dose of quinpirole by dopaminergic autoreceptors.
    Widzowski DV, Cory-Slechta DA.
    J Pharmacol Exp Ther; 1993 Aug; 266(2):526-34. PubMed ID: 8355188
    [Abstract] [Full Text] [Related]

  • 8. Relationship between receptor occupancy and response at striatal dopamine autoreceptors.
    Meller E, Bohmaker K, Namba Y, Friedhoff AJ, Goldstein M.
    Mol Pharmacol; 1987 Jun; 31(6):592-8. PubMed ID: 2885734
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological characterization of dopamine autoreceptors in the rat ventral tegmental area: microiontophoretic studies.
    White FJ, Wang RY.
    J Pharmacol Exp Ther; 1984 Nov; 231(2):275-80. PubMed ID: 6491980
    [Abstract] [Full Text] [Related]

  • 10. Differential agonist profile of the enantiomers of 3-PPP at striatal dopamine autoreceptors: dependence on extracellular dopamine.
    Clark D, Salah RS, Galloway MP.
    Synapse; 1991 Jul; 8(3):169-76. PubMed ID: 1948667
    [Abstract] [Full Text] [Related]

  • 11. RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.
    Arnerić SP, Long JP, Williams M, Goodale DB, Mott J, Lakoski JM, Gebhart GF.
    J Pharmacol Exp Ther; 1983 Jan; 224(1):161-70. PubMed ID: 6401334
    [Abstract] [Full Text] [Related]

  • 12. Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo.
    Galloway MP, Wolf ME, Roth RH.
    J Pharmacol Exp Ther; 1986 Mar; 236(3):689-98. PubMed ID: 3081705
    [Abstract] [Full Text] [Related]

  • 13. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT, White FJ.
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats.
    Imperato A, Tanda G, Frau R, Di Chiara G.
    J Pharmacol Exp Ther; 1988 Apr; 245(1):257-64. PubMed ID: 3258912
    [Abstract] [Full Text] [Related]

  • 15. Effects of N-n-propylnorapomorphine enantiomers on single unit activity of substantia nigra pars compacta and ventral tegmental area dopamine neurons.
    Cox RF, Neumeyer JL, Waszczak BL.
    J Pharmacol Exp Ther; 1988 Oct; 247(1):355-62. PubMed ID: 3171980
    [Abstract] [Full Text] [Related]

  • 16. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
    Claustre Y, Fage D, Zivkovic B, Scatton B.
    J Pharmacol Exp Ther; 1985 Feb; 232(2):519-25. PubMed ID: 2857197
    [Abstract] [Full Text] [Related]

  • 17. The acute and chronic administration of (+/-)-8-hydroxy-2-(Di-n-propylamino)tetralin significantly alters the activity of spontaneously active midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Nakamura K, Suzuki K, McCreary AC, Ashby CR.
    Synapse; 2006 May; 59(6):359-67. PubMed ID: 16463399
    [Abstract] [Full Text] [Related]

  • 18. Dopamine and serotonin release-regulating autoreceptor sensitivity in A9/A10 cell body and terminal areas after withdrawal of rats from continuous infusion of cocaine.
    Chen NH, Reith ME.
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1445-53. PubMed ID: 8263807
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Repeated stimulation of dopamine D2-like receptors: reduced responsiveness of nigrostriatal and mesoaccumbens dopamine neurons to quinpirole.
    Pitts DK, Wang L, Kelland MD, Freeman AS, Chiodo LA.
    J Pharmacol Exp Ther; 1995 Oct; 275(1):412-21. PubMed ID: 7562579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.